ArticleFrontiers in oncology2025

Evaluating the survival outcomes in clinical node stage 2 and 3 breast cancer patients with negative sentinel lymph node biopsy after neoadjuvant chemotherapy: sentinel lymph node biopsy alone vs. axillary lymph node dissection.

Eunju Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.